Back for its 12th Annual edition, this global bio-pharma industry forum addresses through its conference programme the main challenges for 2019 in investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in the different therapeutic sectors. The Forum also features keynote speeches by KOL, about 60 selected corporate presentations from established (public and private) and emerging biotechs seeking to promote investment and partnering opportunities. There is also a focus on early stage innovation and an elevator session with up 20 presentations by start-ups from BioMed and Digital Health.
On site meetings are facilitated by our online 1-2-1 meeting system, which is available to all participants. We expect up to 350 delegates and 1500+ 1-2-1 meetings to take place on site.
Last Year's Plenary Sessions included:
Global Biopharma Industry Review: Prospects for 2018
Private Equity and VC: Latest Trends in Fund Raising and Investment
European Equity Capital Markets: Capital Raising and Investment Opportunities
Bio-Pharma Partnering: Key Players focusing on DealMaking to Alliance Management
Early Stage Innovation
Seed Companies Investor Roundtable
Rising Stars: Start-Up Showcase
Last Year's Therapeutic Panels Included:
Advances in Cell & Gene Therapies
Neuroscience I – BD&L
Neuroscience II – Advanced Therapies and Diagnostics
Sven Kili, VP & Head of Gene Therapy Development, GlaxoSmithKline
Thibaut Roulon, Investment Director, Life Sciences Investments, Bpifrance
Tim Haines, Managing Partner, Abingworth LLP
Tim Herpin, Vice President, Head of Transactions (UK), Business Development, AstraZeneca
Ulrich Kessler, CEO, Inthera Bioscience AG
Ulrich Muehlner, CEO, docdok.health AG
Yochi Slonim, Co-Founder, CEO, Anima Biotech Ltd.
ZhiZhong Yao, Associate, Sofinnova Partners
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at 12th Annual European Life Sciences CEO Forum & Exhibition is an effective way to gain leads, introduce new products and services, expand sales, and build relationships.
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market. Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting, exhibition or sponsorship opportunities, please contact: Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia.
Silver Sponsors in 2018:
Supporters in 2018:
Participating Pharmas in 2018:
Financial, Advisory, Investors in 2018:
Abingworth LLP AGLAIA BioMedical Ventures B.V. Apex Healthcare Consulting Ltd. ATGN Consulting BAG Health Care GmbH Bellevue Asset Management AG BioMedPartners AG BioSeed Capital Bpifrance Breslin AG Capricorn Venture Partners NV Corinthian Financial Edmond de Rothschild Investment Partners Management LTD Creathor Ventures Creathor Ventures Csendes Consulting DDF Ventures Ernst & Young AG European Investment Bank European Investment Fund EVA - the Basel life sciences start-up agency Gilde Healthcare Partners goetzpartners (Schweiz) AG Grabulovski Consulting Services GrowthCube Partners, LLC HBM Partners AG HealthCare Royalty Partners High-Tech Gruenderfonds Management GmbH IBB Beteiligungsgesellschaft GmbH ICF Consult Industrifonden Isis Innovation/University of Oxford (BF) Jefferies International Limited Johnson & Johnson Innovation Kronos Advisors LSP LSRI Medex Capital Merck Ventures B.V. MSC Capital Nextech Invest Ltd. Norgine Ventures Management Limited Novartis Venture Fund Novo Holdings A/S Novo Seeds Novo Ventures Oddo BHF OrbiMed Advisors, LLC Peppermint Venture Partners GmbH PharmaVentures Ltd. Privateq Advisors AG Redalpine Venture Partners Rosetta Capital Ltd. Rothschild Seventure Partners Silicon Valley Bank Sofimac Partners Sofinnova Partners SA Staatz Business Development & Strategy Swiss Tech Capital AG The Fulford Group Ltd. Torreya Partners (Europe), LLC Touchstone Innovations TVM Capital China Limited Ventac Partners GmbH Vesalius Biocapital VI Partners AG Wellington Partners ...More TBA...